Gene: CSDC2
Official Full Name: cold shock domain containing C2provided by HGNC
Gene Summary: Predicted to enable mRNA 3'-UTR binding activity. Predicted to be involved in regulation of mRNA stability. Predicted to be located in nucleus. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27701 | CSDC2 Knockout cell line (HeLa) | Human | CSDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO27702 | CSDC2 Knockout cell line (HEK293) | Human | CSDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO27703 | CSDC2 Knockout cell line (A549) | Human | CSDC2 | 1:3~1:4 | Negative | Online Inquiry |
CSDC2 Gene Knockout Cell Lines are genetically engineered cellular models characterized by the targeted deletion of the CSDC2 gene, which encodes for a protein implicated in various cellular processes including mRNA metabolism and gene expression regulation. These cell lines are instrumental for researchers seeking to elucidate the functional consequences of CSDC2 loss and its link to cellular pathways in health and disease.
The primary function of CSDC2 involves its role in modulating RNA stability and translation, making these knockout cell lines crucial for investigating the underlying mechanisms of gene regulation. By creating a controlled environment with the absence of CSDC2, scientists can explore how this gene contributes to cellular responses and behavior, particularly in processes related to tumor biology, neurological disorders, and response to stress. The use of these knockout models facilitates a deeper understanding of the gene's involvement in disease mechanisms and potential points for therapeutic intervention.
In research and clinical settings, CSDC2 Knockout Cell Lines provide a reliable platform for drug screening and development, allowing for the examination of compound efficacy and mechanism of action against targets that interact with CSDC2. The specificity of these cell lines offers significant advantages over traditional models, as they eliminate confounding factors associated with the presence of functional alleles.
Compared to alternatives, the CSDC2 gene knockout models ensure precise gene manipulation and allow for more reproducible experimental outcomes. They serve as a powerful tool for academic laboratories and biopharmaceutical industries focusing on innovative genetic studies and therapeutic explorations.
Investing in CSDC2 Gene Knockout Cell Lines is invaluable for researchers and clinicians committed to advancing the frontiers of genetic research and therapeutic development. Our company, renowned for its commitment to high-quality genetically engineered cell lines and extensive expertise in molecular biology, ensures that these products meet the highest standards of reliability and functionality, empowering scientists to achieve groundbreaking results in their work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.